Mostrar o rexistro simple do ítem

dc.contributor.authorDíaz-Prado, Silvia
dc.contributor.authorRendal Vázquez, María Esther
dc.contributor.authorMuiños-López, Emma
dc.contributor.authorHermida Gómez, Tamara
dc.contributor.authorRodríguez-Cabarcos, Margarita
dc.contributor.authorFuentes Boquete, Isaac Manuel
dc.contributor.authorDe-Toro, Javier
dc.contributor.authorBlanco García, Francisco J
dc.date.accessioned2015-06-16T11:46:48Z
dc.date.available2015-06-16T11:46:48Z
dc.date.issued2010-04-13
dc.identifier.citationDíaz-Prado S, Rendal-Vázquez ME, Muíños-López E, Hermida-Gómez T, Rodríguez-Cabarcos M, Fuentes-Boquete I, et al. Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair. Cell Tissue Bank. 2010;11:183-195.es_ES
dc.identifier.urihttp://hdl.handle.net/2183/14686
dc.description.abstract[Abstract] The human amniotic membrane (HAM) is an abundant and readily obtained tissue that may be an important source of scaffold for transplanted chondrocytes in cartilage regeneration in vivo. To evaluate the potential use of cryopreserved HAMs as a support system for human chondrocytes in human articular cartilage repair. Chondrocytes were isolated from human articular cartilage, cultured and grown on the chorionic basement membrane side of HAMs. HAMs with chondrocytes were then used in 44 in vitro human osteoarthritis cartilage repair trials. Repair was evaluated at 4, 8 and 16 weeks by histological analysis. Chondrocytes cultured on the HAM revealed that cells grew on the chorionic basement membrane layer, but not on the epithelial side. Chondrocytes grown on the chorionic side of the HAM express type II collagen but not type I, indicating that after being in culture for 3–4 weeks they had not de-differentiated into fibroblasts. In vitro repair experiments showed formation on OA cartilage of new tissue expressing type II collagen. Integration of the new tissue with OA cartilage was excellent. The results indicate that cryopreserved HAMs can be used to support chondrocyte proliferation for transplantation therapy to repair OA cartilage.es_ES
dc.description.sponsorshipThis study was supported by grants: Servizo Galego de Saúde, Xunta de Galicia (PS07/84), Catedra Bioiberica de la Universidade da Coruña and Instituto de Salud Carlos III CIBER BBN CB06-01-0040. Silvia Diaz-Prado is beneficiary of an Isidro Parga Pondal contract from Xunta de Galicia, A Coruna, Spain. Tamara Hermida-Gómez is beneficiary of a contract from Fondo de Investigación Sanitaria (2008), Spain. Emma Muíños-López is supported by Rheumatology Spanish Foundation, Spain. We would like to thank MJ Sánchez and P Filgueira for technical assistance.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB06-01-0040
dc.description.sponsorshipXunta de Galicia; PS07/84
dc.language.isoenges_ES
dc.publisherSpringeres_ES
dc.relation.urihttp://dx.doi.org/10.1007/s10561-009-9144-1es_ES
dc.rightsThe final publication is avaliable at link.spinger.comes_ES
dc.subjectAmniotic membranees_ES
dc.subjectChondrocyteses_ES
dc.subjectCartilagees_ES
dc.subjectOsteoarthritises_ES
dc.subjectCell therapyes_ES
dc.titlePotential use of the human amniotic membrane as a scaffold in human articular cartilage repaires_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES


Ficheiros no ítem

Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem